Parliament

Dr Muriel Newman is the founding Director of the New Zealand Centre for Political Debate.

 Muriel, a founding member of ACT New Zealand and a Member of Parliament from 1996-2005, has a Bachelor of Science degree in mathematics from Auckland University and Doctorate in Mathematics Education from Rutgers University, New Jersey, USA.

Her early career- spanning almost 20 years - was in the education field at secondary and tertiary level in NZ and the USA . She became involved in the agriculture sector while running the family farm and raising her children, later moving into retail to become the NZ Assistant General Manager for Michael Hill Jeweller.

During that time, she was elected President of the Northland Chamber of Commerce, and was appointed to the Northland Area Health Board, the Northland Conservation Board and the Northland Business Development Board.

She is the joint author with her husband, Frank, of several books about money management (including the popular "How to Live Off the Smell of an Oily Rag" series), holds a black belt in Kung Fu and lives at Rocky Bay Cove in Tutukaka, Whangarei.

email muriel@newman.co.nz, phone 021 800 111, or post PO Box 984 , Whangarei.

Prostate Cancer Screening Petition to Parliament
Dr Muriel Newman and 585 others

The Petition

This petition to Parliament, signed by 585 supporters, is promoting the need for a national prostate-screening programme for men.

The Disease

Prostate cancer is a disease of the prostate gland. It occurs when the cells of the prostate begin to grow uncontrollably. This usually occurs in men over the age of 40.

There is a very strong genetic link with prostate cancer: men who have a father or grandfather with the disease are very likely to get it themselves.

When caught and treated early, prostate cancer has a cure rate of over 90%.

The Situation

Prostate cancer is the most common form of cancer in New Zealand.

According to the latest New Zealand Health Information Service data, in 2001 there were 17,913 people diagnosed with cancer, of which 3,046 were men with prostate cancer. Of the 7,810 people who died of cancer in that year, 592 men died of prostate cancer.

Diagnosis

The most common method of detecting prostate cancer is through the use of a blood test called the prostate specific antigen (PSA) test, a digital rectal examination (DRE), and a biopsy. A 'two step' screening process is preferred with PSA and DRE tests being used in the first instance to be followed up by a biopsy where necessary. This is similar to the practice used for breast cancer, whereby a biopsy of suspicious lesions is undertaken only after a mammography and clinical examination indicates the need for further tests.

The rate of “false positives” for the PSA test is similar to the rate of false positives in breast cancer screening.

Early Screening Saves Lives

According to the President of the New Zealand Prostate Cancer Foundation, “the insidious thing about prostate cancer is that in it’s early stages it does not generally exhibit symptoms, so a man may be walking around with the disease and not know it. If he does begin to get symptoms, and these turn out to be caused by prostate cancer, then the cancer is much less amenable to treatment”.

Urologists have advised the Foundation that some 300 lives a year could be saved if prostate cancer is diagnosed early enough.

Ministry of Health Advice

Yet, in spite of the evidence that early screening can save lives, and that the symptoms of prostate cancer are often not recognisable until the disease is in an advanced and incurable state, the advice being given by the Ministry of Health to doctors and patients is that checking for prostate cancer is not recommended for men without symptoms:  

“The National Health Committee do not recommend routine screening of men without symptoms for prostate cancer in New Zealand”.

Screening

With medical evidence showing that with early detection can save 90% of lives, PSA screening is routine in several countries including the USA and Germany.

Here in New Zealand the Prostate Cancer Foundation advises men with a family history of prostate cancer to have regular checks from the age of 40, and other men from the age of 50.

In contrast, by advising against testing unless symptoms are present, our Government could be jeopardising the health and wellbeing of many New Zealand men.

The Petitioners Request

The petitioners would like to ask that this Select Committee recommend to Government that a national prostate-screening programme for men be introduced.

We would, however, like this request to be considered in the context of the statistics surrounding the Government’s cervical cancer and breast cancer screening programmes: in 2001 189 women were diagnosed with cervical cancer and 63 women died from that disease, while 2,310 women were diagnosed with breast cancer and 615 died.

In comparison, over 3,000 men were diagnosed with prostate cancer, and almost 600 died, but instead of a national screening programme being in place, there is a government recommendation advising against any form of early screening at all.

Surely the Committee cannot condone this state of affairs?

Thank you for your consideration of our request. I would be happy to discuss this with the Committee if appropriate.

Dr Muriel Newman
PO Box 984
Whangarei
021-800-111
muriel@newman.co.nz
31 March 2006